retatrutide clinical trials phase 2 Eli Lilly infiltrates anti-obesity market as III trial for begins Triple hormone receptor agonist retatrutide

Connolly JPR, Slater SL, OBoyle N, Goldstone RJ, Crepin VF, Gallego DR, et al

GLP-1 is the hormone responsible for inhibiting the production of glucagon and promoting the production of insulin

Anyone with a history of pancreatitis, severe gastrointestinal disease, or significant kidney impairment should raise these conditions with a clinician before any GLP-1 evaluation

M., Marzano, S., Lopez, R

Its unique role in the brain-gut axis supports both gut health and neuroprotection, influencing neurotransmitter balance and nerve regeneration, making it relevant for inflammatory disorders, injuries, and neurodegenerative diseases